Proof of Concept, Randomized, and Crossover Study, to Assess the Effectiveness of Two Types of Compression Garments in Lipedema

ConditionLipedema
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorIsabel Forner-Cordero, MD, PhD

About this trial

The goal of this prospective randomized crossover experimental study is to assess the effectiveness and tolerance of circular and flat fabric garments in stabilizing lower-limb volume in lipedema. It will assess the effectiveness of the garments and determine any differences between both types of hosiery currently used in routine clinical practice. Participants will be prescribed either circular or flat-knitted pantyhose and wear them daily for 6 months. After 6 months, they will change the type of garment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical diagnosis of lipedema: increased lowe-limb volume, disproportion between upper and lower body, and pain.

Lipedema type III stages 1 or 2.

Negative pitting sign.

In maintenance treatment phase with a class II circular-knitted compression garment for at least 6 months.

Disqualifiers

Lipedema with fatty lobulations.

Body Mass Index (BMI) ≥ 30 kg/m2.

Waist-to-Height Ratio > 0.53.

Pregnancy.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Flat-knitted compression garment

    Device

    Flat knitted compression garments

Treatment groups

34 Participants
are divided into 2 treatment groups
Group A: Circular-knitted compression garmentsActive comparator 1 intervention
Group B: Flat-knitted compression garmentsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Percentage of Volume Change (PVC)

The Percentage of Volume Change (PVC) at the 6th and 12th month of treatment is calculated using the following mathematical formula: PVC = \[ (Baseline volume- final volume)/ baseline volume\] x 100 Where: * Baseline is the reference volume at the beginning of the treatment. * Final Volume is the volume at the end of the treatment period (either at the 6th or 12th month). This calculation provides the percentage change in volume of the lower limbs over the course of the treatment period compared to the initial volume. We consider maintenance treatment is successful when the Percentage of Volume Change (PVC) is \<10% after 6 or 12 months of treatment, relative to the study's baseline. We define disease progression when the PVC is \>10% at 6 or 12 months, relative to the study's baseline.

Time frame
at the 6th and 12th month of treatment

Secondary outcomes

1

Pain intensity

Pain in lower limbs: visual analogue scale (VAS). Scores range from 0 (absent) to 10 (worst possible).

Time frame
at the 6th and 12th month of treatment
2

Heaviness

Perceived heaviness in lower limbs: visual analogue scale (VAS). Scores range from 0 (absent) to 10 (worst possible).

Time frame
at the 6th and 12th month of treatment
3

Numbness

Numbness in lower limbs: visual analogue scale (VAS). Scores range from 0 (absent) to 10 (worst possible).

Time frame
at the 6th and 12th month of treatment
4

Characteristics of pain

Location and type of sensation.

Time frame
at the 6th and 12th month of treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Isabel Forner-Cordero, MD, PhD

Lead sponsor

Instituto de Investigacion Sanitaria La Fe

Sponsor institution

Hospital Provincial de Castellon

Collaborator

Hospital Arnau de Vilanova

Collaborator